241 related articles for article (PubMed ID: 30376220)
1. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
Russell-Goldman E; Hornick JL; Qian X; Jo VY
Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
[TBL] [Abstract][Full Text] [Related]
3. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.
McCuiston A; Bishop JA
Head Neck Pathol; 2018 Mar; 12(1):89-94. PubMed ID: 28616785
[TBL] [Abstract][Full Text] [Related]
5. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.
Shibuya R; Matsuyama A; Nakamoto M; Shiba E; Kasai T; Hisaoka M
Virchows Arch; 2014 Nov; 465(5):599-605. PubMed ID: 25031013
[TBL] [Abstract][Full Text] [Related]
6. Correlation NKX2.2 IHC and
Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
[TBL] [Abstract][Full Text] [Related]
7. Primary pancreatic Ewing sarcoma: a cytomorphologic and histopathologic study of 13 cases.
Miller DL; Roy-Chowdhuri S; Illei P; James A; Hruban RH; Ali SZ
J Am Soc Cytopathol; 2020; 9(6):502-512. PubMed ID: 32536453
[TBL] [Abstract][Full Text] [Related]
8. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
[TBL] [Abstract][Full Text] [Related]
9. The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma.
Rooper LM; Sharma R; Gocke CD; Belchis DA
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):174-179. PubMed ID: 28800015
[TBL] [Abstract][Full Text] [Related]
10. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
Chebib I; Jo VY
Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Nov; 29(11):1324-1334. PubMed ID: 27443513
[TBL] [Abstract][Full Text] [Related]
13. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody.
Rossi S; Orvieto E; Furlanetto A; Laurino L; Ninfo V; Dei Tos AP
Mod Pathol; 2004 May; 17(5):547-52. PubMed ID: 15001993
[TBL] [Abstract][Full Text] [Related]
14. ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions.
Le Guellec S; Velasco V; Pérot G; Watson S; Tirode F; Coindre JM
Mod Pathol; 2016 Dec; 29(12):1523-1531. PubMed ID: 27562494
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of MIC-2 immunocytochemical staining in the differential diagnosis of small blue cell tumors.
Halliday BE; Slagel DD; Elsheikh TE; Silverman JF
Diagn Cytopathol; 1998 Dec; 19(6):410-6. PubMed ID: 9839129
[TBL] [Abstract][Full Text] [Related]
16. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract][Full Text] [Related]
17. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls-Comment on Russell-Goldman et al.
Creytens D
Cancer Cytopathol; 2019 Mar; 127(3):202. PubMed ID: 30720925
[No Abstract] [Full Text] [Related]
18. PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours.
Toki S; Wakai S; Sekimizu M; Mori T; Ichikawa H; Kawai A; Yoshida A
Histopathology; 2018 Oct; 73(4):645-652. PubMed ID: 29920735
[TBL] [Abstract][Full Text] [Related]
19. A case report of CIC-rearranged undifferentiated small round cell sarcoma in the cerebrum.
Ito M; Ishikawa M; Kitajima M; Narita J; Hattori S; Endo O; Goto K
Diagn Cytopathol; 2016 Oct; 44(10):828-32. PubMed ID: 27324529
[TBL] [Abstract][Full Text] [Related]
20. Ewing sarcoma and Ewing-like tumors.
Sbaraglia M; Righi A; Gambarotti M; Dei Tos AP
Virchows Arch; 2020 Jan; 476(1):109-119. PubMed ID: 31802230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
